Downregulates of ICAM1 expression in Myometrium from pregnant Rattus novergicus infected with Tachyzoite of Toxoplasma gondii with Hyperbaric Oxygen Therapy
<p align="center"><strong>Abstract</strong></p><p><strong>Background:</strong> To find the effect of Hyperbaric Oxygen Therapy in the myometrium expressions of ICAM1 from pregnant Rattus norvegicus infected with Tachyzoite <em>Toxoplasma gondii.</em></p><p><strong>Material and Methods :</strong></p><p>This is an experimental study with a post-test only design on 37 pregnant <em>Rattus norvegicus</em> <em>Sprague Dawley</em>, then the rats were divided into 4 groups. The HBOT group A is pregnant rats infected with tachyzoite received therapy 10 sessions of HBOT 2.4 ATA in 3x30 minutes; the group B is Pregnant only and get no HBOT; the group C is Pregnant and infected with <em>tachyzoite T.gondii</em> but not received HBOT, and the group D is normal pregnant rats. Each infected pregnant rats were given a 10<sup>3 </sup>Tachyzoite of <em>Toxoplasma gondii</em> via intraperitoneal. Examinations of ICAM1 expressions were performed on day-5 after HBOT (twice a day). Rats were killed and the myometrial ICAM1 levels were measured with Immunohistochemistry examination. All data were analyzed with the ANOVA test with SPSS 21 Program.<strong></strong></p><p><strong>Results: </strong>The results show that Hyperbaric Oxygen Therapy can downregulate ICAM1 in the administered of HBO 2.4 ATA for 3x30 minutes in 10 sessions over 5 days of therapy.</p><p><strong>Conclusion:</strong> The study concludes that HBOT can downregulate the expressions of ICAM1 in the myometrium, in the provision of HBO 2.4 ATA for 3x30 minutes in 10 sessions.</p>